1339:HKEXThe People's Insurance Company (Group) of China Limited Analysis
Data as of 2026-07-27 - not real-time
NT$44.55
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The stock is trading just above its 20‑day SMA and remains in a bullish trend despite a bearish MACD histogram, while RSI hovers around the neutral 50 level, suggesting limited upside momentum. Volume is on a downtrend and the market sentiment index reads “Extreme Greed,” indicating that short‑term buying pressure may be fading. Beta is exceptionally low at 0.16, pointing to minimal systematic risk, but 30‑day volatility of roughly 19% adds a moderate price swing risk.
Fundamentally, revenue has contracted by about 20% and operating margin is slightly negative, raising concerns about profitability. The company pays a high dividend yield of 5.6% but the payout ratio exceeds 120%, making the dividend potentially unsustainable. Moreover, the DCF‑derived fair value of roughly 23 TWD is less than half the current price of 44.5 TWD, flagging the stock as significantly overvalued relative to intrinsic estimates.
Fundamentally, revenue has contracted by about 20% and operating margin is slightly negative, raising concerns about profitability. The company pays a high dividend yield of 5.6% but the payout ratio exceeds 120%, making the dividend potentially unsustainable. Moreover, the DCF‑derived fair value of roughly 23 TWD is less than half the current price of 44.5 TWD, flagging the stock as significantly overvalued relative to intrinsic estimates.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price marginally above short‑term moving average
- Decreasing trading volume
- Neutral RSI and bearish MACD histogram
Medium Term
1–3 yearsCautious
Model confidence: 6/10
Key Factors
- Revenue decline and negative operating margin
- Overvaluation relative to DCF fair value
- Unsustainable dividend payout
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- Low beta indicating defensive characteristics
- Strong cash position versus modest debt
- Potential turnaround if cost structure improves
Key Metrics & Analysis
Financial Health
Revenue Growth-20.20%
Profit Margin20.09%
P/E Ratio18.5
ROE8.04%
ROA1.88%
Debt/Equity6.94
P/B Ratio0.8
Op. Cash FlowNT$774.8M
Free Cash FlowNT$73.1M
Technical Analysis
TrendBullish
RSI52.3
SupportNT$43.05
ResistanceNT$46.30
MA 20NT$44.58
MA 50NT$43.72
MA 200NT$43.07
MACDBearish
VolumeDecreasing
Fear & Greed Index90.04
Valuation
Fair ValueNT$23.44
GradeOvervalued
TypeValue
Dividend Yield5.64%
Risk Assessment
Beta0.16
Volatility19.16%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.